Metabolic Profiling of Immune Responses in Immune-mediated Diseases

08 Apr 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Primary Immunodeficiency · Enrollment 300 · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 08 Apr 2026. The item focuses on Metabolic Profiling of Immune Responses in Immune-mediated Diseases. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT04864886

Open Original Source More Feed Items

Related by Condition/Drug

Long-term anakinra therapy in Schnitzler syndrome: real-world evidence on remission of neutrophilic dermatitis and systemic inflammation, safety, biomarker insights and dose optimization

Infectious Disease • 04 May 2026

Case Report: Sustained immune and pulmonary recovery three years after hematopoietic stem cell transplantation for ITCH E3 ubiquitin ligase deficiency

Infectious Disease • 01 May 2026

A spatially coordinated keratinocyte–fibroblast circuit recruits MMP9⁺ myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity

Infectious Disease • 24 Apr 2026

BMJ OpenRelated by Conditionpsoriasis

Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings

Research Highlights • 19 May 2026

STATRelated by Conditionpsoriasis

STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more

Research Highlights • 14 May 2026

STATRelated by Conditionpsoriasis

Mid-Stage Trial: Oruka’s Long-Acting Psoriasis Injection Shows 63% Complete Clearance

Research Highlights • 27 Apr 2026

Feed Metadata

Source

ClinicalTrials.gov